Clinical Trial

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Study acronym: Cytalux
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-23; most recent amendment 2026-06-03.
Status change: Not Yet Recruiting → Recruiting 2024-08-20
Trial Details
NCT Number NCT06235125
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: On Target Laboratories, LLC
Conditions Osteosarcoma, Pulmonary Metastasis, Fluorescence, Metastatic Sarcoma, Pediatrics
Enrollment 10 participants
Start Date 2024-04-08
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-05